Sunil Srivastava, MD
Ophthalmology · Cleveland, OHNPI 1225094378
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $399,463 of the $507,581 with a category attached, or 78.7%. 19 manufacturers reported payments, led by Novartis at 48.7% of the total. Reporting peaked in 2020 at $188,496 and has fallen 85.9% since, to $26,485 in 2025. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $1762.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$247K
- Bausch & Lomb Americas Inc.$82K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$76K
- Regeneron$21K
- Eyepoint US, Inc.$17K
- Carl Zeiss Meditec, Inc.$13K
- plus $51K from 13 others
Across 94 payments — averaging $25,651 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2M
- Eyepoint US, Inc.$321K
- Novartis Pharma AG$59K
- Novartis$37K
- Bausch Health US, LLC$7K
- F. Hoffmann-la Roche AG$4K
What the payments were for
- Consulting fees$399,46379%
- Speaking & faculty fees$61,40012%
- Grants$17,0003%
- Travel & lodging$18,1734%
- Food & beverage$11,5082%
- Entertainment$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $247,442 |
| Bausch & Lomb Americas Inc. | 92 | $81,838 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 69 | $76,025 |
| Regeneron | 25 | $21,163 |
| Eyepoint US, Inc. | 20 | $17,042 |
| Carl Zeiss Meditec, Inc. | 10 | $13,048 |
| Merck | 9 | $9,512 |
| AbbVie(2 entities) | 6 | $9,422 |
| Sanofi US Services Inc. | 1 | $7,950 |
| Regeneron Healthcare Solutions, Inc. | 10 | $5,629 |
| Genentech USA, Inc. | 2 | $4,710 |
| Ocular Therapeutix, Inc. | 4 | $4,522 |
| Kala Pharmaceuticals, Inc. | 1 | $4,500 |
| Gilead | 6 | $3,378 |
| Apellis Pharmaceuticals, Inc. | 5 | $553 |
| Alcon | 1 | $395 |
| Alimera Sciences, Inc. | 3 | $329 |
| Dompe US, Inc. | 1 | $85 |
| Optos PLC | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEOVU$141,550
- STELLARIS$86,358
- OPHTHALMIC INSTRUMENTS$31,973
- STELLARIS ELITE$25,460
- YUTIQ$16,445
- VITESSE$15,946
- EYLEA$12,803
- Bausch + Lomb$12,402
- STELLARIS PC$9,731
- XIPERE$9,724
- LIGHT PIPES$9,630
- Humphrey HFA$8,250
- VISUDYNE$8,250
- CLARUS 500$7,700
- Glaucoma Workplace$7,700
- Retina Workplace$7,700
- XIIDRA$7,661
- MIEBO$7,661
- Laser Probes$7,500
- CIRRUS HD-OCT$6,860
How this compares
$507,581 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Difluprednate | 94 | $14,458 |
| Prednisolone Acetate | 222 | $10,200 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 105 | $1,492 |
| ValacyclovirValacyclovir Hcl | 39 | $1,199 |
| Timolol Maleate | 72 | $795 |
| Brimonidine Tartrate | 40 | $536 |
| Latanoprost | 65 | $529 |
| Prednisone | 86 | $511 |
| Atropine Sulfate | 11 | $438 |
| Ketorolac Tromethamine | 25 | $376 |
| ErythromycinErythromycin Base | 23 | $259 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cleveland
- Peter KaiserCleveland$1.5M
- Justis EhlersCleveland$639K
- William WileyCleveland$479K
- Yasha ModiCleveland$234K
- Faruk OrgeCleveland$158K
- Danny MammoCleveland$149K
- Douglas RheeCleveland$138K
- Jeffrey GosheCleveland$82K
- William DuppsCleveland$44K
- Shree KurupCleveland$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.